• EOPatch submitted for KFDS regulatory approval

  • EOFLOW recently applied for the regulatory approval of its first commercial product, EOPatch, with KFDS (Korean Food and Drug Safety).  EOPatch is made up of a wearable disposable insulin pump patch ('Patch'), a smart-phone like controller ('ADM: Advanced Diabetes Manager'), and a management software that runs on a computer ('DDM: Diabetes Data Manager'). 

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here